XIST和MUC1-C形成了一种自我调节的途径,可以促进癌症的进展
Keyi Wang1, Atrayee Bhattacharya1, Naoki Haratake1
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Cell death & disease
|May 13, 2024
概括
MUC1-C和XISTRNA形成了一个调节循环,影响癌症的进展. 这个轴,涉及m6A甲基化和NF-κB,驱动茎和自我更新,突出其在癌症中的作用.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 长非编码RNAXIST和MUC1基因在慢性炎症和癌症中失调.
- XIST和MUC1-C之间的功能相互作用在很大程度上是未知的.
研究的目的:
- 阐明MUC1-C和XIST之间的监管关系.
- 研究MUC1-C/XIST途径在癌症进展,干性和自我更新中的作用.
主要方法:
- 通过m6A甲基化复合组件 (RBM15/B,WTAP,METTL3/14) 调查了XIST的MUC1-C调节.
- 评估了MUC1-C通过YTHDF2-CNOT1死亡酶复合体对XIST衰变的影响.
- 研究了XIST通过NF-κB信号传递对MUC1-C表达的调节.
- 分析了共享的下游目标,包括miR-21和TDP-43.
- 研究了TDP-43对MUC1-C/XIST通路的影响.
主要成果:
- MUC1-C通过抑制m6A甲基化和促进XIST衰变来抑制XIST水平.
- 通过NF-κB介导的激活,XIST促进MUC1-C的表达.
- 该MUC1-C/XIST途径调节与炎症和干结相关的常见基因 (miR-21,TDP-43).
- TDP-43调节MUC1-C/XIST通路,该通路驱动茎状,对癌细胞自我更新至关重要.
结论:
- 在MUC1-C和XIST之间确定了一个新的自我调节轴.
- 这种MUC1-C/XIST通路在促进癌症干和自我更新方面发挥着关键作用.
- MUC1-C/XIST轴代表了癌症进展中的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


